Medicine recalls
|
| |
| The United States: Man of Steel 1 and Man of Steel 2: Recall - undeclared drug ingredient |
| |
The US Food and Drug Administration (FDA) announces that Man of Steel is voluntarily recalling 175 lots of Man of Steel 1 and Man of Steel 2, 4000mg at the retail level. The products have been found to contained undeclared sildenafil. The product has/potentially could result in death. The groups affected are men with diabetes, high blood pressure, high cholesterol, or heart disease. The product is marketed as a male enhancement supplement and is packaged in individual blister package. The affected product Man of Steel lots include the following expiration dates: 10-17-18. Man of Steel was distributed throughout local convenience stores in Sacramento, California.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/MedWatch/../ucm569250.htm
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by FDA, and was posted on the Drug Office website on 23 Jun 2017.
Ends/Tuesday, Aug 1, 2017
Issued at HKT 14:00
|
| |
|
